BTTX

Better Therapeutics, Inc. BTTX

BTTX
Better Therapeutics, Inc. ONPH
Oncology Pharma Inc. PANC
Panacos Pharmaceuticals, Inc. AMPE
Ampio Pharmaceuticals, Inc. CALA
Calithera Biosciences, Inc. KLDO
Kaleido Biosciences, Inc. ARNI
Arno Therapeutics, Inc. BXRXQ
Baudax Bio, Inc. TLOG
TetraLogic Pharmaceuticals Corporation SCIE
SpectraScience, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode BTTX ONPH PANC AMPE CALA KLDO ARNI BXRXQ TLOG SCIE
6M 0.00 % 3 900.00 % 0.00 % 92.59 % 400.00 % 0.00 % 100.00 % 0.00 % 0.00 % 0.00 %
YTD 0.00 % 3 900.00 % 0.00 % 100.00 % 66.67 % 0.00 % 100.00 % 900.00 % 0.00 % 0.00 %
1Y 0.00 % 3 900.00 % 0.00 % 100.00 % 400.00 % 0.00 % 100.00 % 900.00 % 0.00 % 0.00 %
3Y -99.99 % -99.00 % 9 900.00 % -99.88 % -99.98 % -90.91 % 19 900.00 % -99.96 % 0.00 % 0.00 %
5Y -100.00 % -99.11 % -90.00 % -100.00 % -100.00 % -100.00 % -91.67 % -99.96 % -99.31 % 0.00 %
10Y -100.00 % -100.00 % 9 900.00 % -99.99 % -100.00 % -100.00 % -99.92 % -99.96 % -99.99 % -99.99 %
From the beginning -100.00 % -100.00 % -99.99 % -99.99 % -100.00 % -100.00 % -100.00 % -99.96 % -100.00 % -100.00 %

Dividend